Royce & Associates LP Cv Rx, Inc. Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$11.67 - $33.01 $508,625 - $1.44 Million
43,584 Added 61.9%
114,000 $3.58 Million
Q3 2023

Nov 09, 2023
BUY
$13.56 - $18.47 $87,000 - $118,503
6,416 Added 10.03%
70,416 $1.07 Million
Q2 2023

Aug 07, 2023
BUY
$8.57 - $15.44 $548,480 - $988,160
64,000 New
64,000 $988,000

Others Institutions Holding CVRX

# of Institutions
84
Shares Held
14.4M
Call Options Held
56.3K
Put Options Held
41.8K
View Full List

About CVRx, Inc.

CVRX Quotes by TradingView
  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $292M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email